Sonoma Pharmaceuticals (SNOA) Notes Payables (2022 - 2025)

Sonoma Pharmaceuticals' Notes Payables history runs 4 years deep, the most recent figure standing at $56000.0 for Q3 2025.

• In Q3 2025, Notes Payables fell 31.71% year-over-year to $56000.0; the TTM figure through Sep 2025 stood at $56000.0 (down 31.71% YoY), while the FY2025 annual figure was $220000.0, down 31.89% from the prior year.
• Notes Payables was $56000.0 for Q3 2025 at Sonoma Pharmaceuticals, down from $139000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $431000.0 in Q1 2023 to a low of $56000.0 in Q3 2025.
• Historically, Notes Payables has averaged $196875.0 across 4 years, with a median of $171500.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Notes Payables soared 259.17% in 2023, then sank 31.89% in 2025.
• A 4-year view of Notes Payables shows it stood at $120000.0 in 2022, then jumped by 259.17% to $431000.0 in 2023, then sank by 80.97% to $82000.0 in 2024, then plunged by 31.71% to $56000.0 in 2025.
• The last three Notes Payables figures came in at $56000.0 (Q3 2025), $139000.0 (Q2 2025), and $220000.0 (Q1 2025), per Business Quant data.